ARC-19499
ARC-19499 Uses, Dosage, Side Effects, Food Interaction and all others data.
ARC-19499 is under investigation in clinical trial NCT01191372 (First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients).
Trade Name | ARC-19499 |
Generic | ARC-19499 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here ARC-19499